Activaero Milestones

1998 
Foundation of Inamed GmbH

2001  
Center for logistics and administration opens in Gemuenden

2002 
Market launch of the first AKITA^® inhalation system

2003  
Exclusive licensing agreement with Talecris Biotherapeutics for the development of inhaled Alpha-1- Antitrypsin for the treatment of emphysema

2004  
The CRO (Inamed) and devices division (Activaero) split into separate companies

2006  
Marktet launch of the AKITA² APIXNEB^TM inhalation system for clinical studies and pharma partnering - the device receives the reddot Design Award.

2007  
Receipt of the US market approval for AKITA² APIXNEB^TM inhalation system.

2008  
Licensing agreement with Bayer HealthCare GmbH for the development of inhalation therapies.

2009  
Market launch of the AKITA^® JET inhalation system in Germany - close of a
10.7 Euro million Series A financing round for own clinical development programs.

2009  
Receipt of the US market approval for AKITA^® JET inhalation system - Activaero wins under the category "Market and Customer" at the F.A.Z. Institute's STEP Awards.